(Q37928163)

25 August 2017

1 reference

title

Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission (English)

1 reference

25 August 2017

1 reference

poliovirus

1 reference

2

Roland W Sutter

1 reference

25 August 2017

Hiromasa Okayasu

1

1 reference

25 August 2017

Cecil Czerkinsky

series ordinal

3

1 reference

25 August 2017

Pearay L Ogra

series ordinal

4

1 reference

25 August 2017

language of work or name

English

0 references

publication date

5 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

29

1 reference

25 August 2017

46

1 reference

25 August 2017

8205-8214

1 reference

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Antigenic structure of polioviruses of serotypes 1, 2 and 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Asymptomatic Wild‐Type Poliovirus Infection in India among Children with Previous Oral Poliovirus Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

New strategies for the elimination of polio from India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Monovalent type 1 oral poliovirus vaccine in newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Effectiveness of immunization against paralytic poliomyelitis in Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Vaccine policy changes and epidemiology of poliomyelitis in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Experiences associated with the use of live poliovirus vaccine in Hungary, 1959-1982.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Inactivated poliovirus vaccine and the final stages of poliovirus eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Regulation of adaptive immunity by the innate immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Innate immunity of the newborn: basic mechanisms and clinical correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Induction of antigen-specific immunity in human neonates and infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Systemic and mucosal immune response to polio vaccination with additional dose in newborn period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Preterm infants' T cell responses to inactivated poliovirus vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Polio immunity to killed vaccine: an 18-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Gut-homing (alpha(4)beta(7)(+)) Th1 memory responses after inactivated poliovirus immunization in poliovirus orally pre-immunized donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Immunological memory in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Maintenance of B-cell memory by long-lived cells generated from proliferating precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Improving the performance of enteric vaccines in the developing world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Synergism of nutrition, infection, and immunity: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Effect of nutritional deprivation on mucosal viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Evaluation of immune response in infants with different nutritional status: vaccinated against tuberculosis, measles and poliomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Vitamin A supplementation of women postpartum and of their infants at immunization alters breast milk retinol and infant vitamin A status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Effect of diarrhea on the humoral response to oral polio vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Child undernutrition, tropical enteropathy, toilets, and handwashing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Enhancement of Immune Response in Peyer's Patch Cells Cultured with Bifidobacterium breve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Perspectives on mucosal vaccines: is mucosal tolerance a barrier?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Effect of Sabin Type 1 poliomyelitis vaccine administered by mouth to newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Oral polio immunization of the newborn infant; a possible method for overcoming interference by ingested antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Modulation of the immune system by human milk and infant formula containing nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Influence of Mycobacterium bovis Bacillus Calmette-Guerin on Antibody and Cytokine Responses to Human Neonatal Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Mucosal vaccines: novel advances in technology and delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

Ontogeny of the gut-associated lymphoid system in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.08.059

1 reference

25 August 2017

1 reference